factMR-logo.png
Blood Transfusion Diagnostics Market to reach US$ 8.7 Billion by 2032; Blood Grouping to expand at a 5.8% CAGR: Fact.MR
December 07, 2022 14:00 ET | FACT.MR
Rockville, Dec. 07, 2022 (GLOBE NEWSWIRE) -- According to a recent report by Fact.MR, a market research and competitive intelligence provider, market of blood transfusion diagnostics is predicted to...
Quotient Limited logo
Quotient Limited Announces CFO Transition
November 02, 2016 16:15 ET | Quotient Limited
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financial...
Quotient Limited logo
Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results
October 31, 2016 16:15 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported further progress on the commercial scale-up of...
Quotient Limited logo
Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results
October 21, 2016 08:30 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s executive management team will...
Quotient Limited logo
Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
October 17, 2016 08:30 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal...
Quotient Limited logo
Quotient Limited Announces $120 Million Secured Debt Financing
October 14, 2016 16:01 ET | Quotient Limited
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private...
Quotient Limited logo
Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
September 08, 2016 16:05 ET | Quotient Limited
MosaiQTM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQTM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood...
Quotient Limited logo
Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
August 08, 2016 16:15 ET | Quotient Limited
Facility modification completed – humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumablesValidation of the initial manufacturing system for MosaiQ™...
Quotient Limited logo
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
August 03, 2016 16:05 ET | Quotient Limited
JERSEY, Channel Islands, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering...
Quotient Limited logo
Quotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call
August 01, 2016 08:30 ET | Quotient Limited
JERSEY, Channel Islands, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first...